维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="Grupp SA"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Chimeric antigen receptor-and TCR-modified T cells enter main street and wall street显示文摘	Barrett DM Grupp SA June CH	2015	J Immunol2015，195，3：	1
2	Targeting the PI3K/ AKT/mTOR signaling axis in children with hematologic malignancies 显示文摘	Barrett D Brown VI Grupp SA	2012	Paediatr Drugs2012，14，5：	1
3	Chimeric antigen receptor-modified T ceils for acute lymphoid leukemia 显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
4	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
5	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia 显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，：	1
6	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D eta/	2013	N EnglJ Med2013，368，16：	1
7	The angiogenesis inhibitor tnp - 470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease显示文摘	Shusterman S Grupp SA Barr R	2001	Clin Cancer Res2001，7，4：	1
8	Chimeric antigen recep- tor-modified T cells for acute lymphoid leukemia 显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
9	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
10	T cells engineered with a chimeric antigen receptor(CAR) targeting CD19(CTL019) have long term persistence and induce durable remissions in children with relapsed,refractory ALL显示文摘	Grupp SA Maude SL Shaw P	2014	Blood2014，124，21：	1
11	Antibody-modified T ceils: CARs take the front seat for hematologic malignancies显示文摘	Maus MV Grupp SA Porter DL	2014	Blood2014，123，17：	1
12	Chimeric antigen receptor- modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
13	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
14	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia 显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
15	Chimeric antigen receptor- modified T cells for acute lymphoid leukemia 显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，16：	1
16	Chimeric antigen receptor T cells directed against CD19 induce durable responses and transient cytokine release syndrome in relapsed, refractory CLL and ALL 显示文摘	Porter DL Grupp SA Kalos M	2012	ASH Annual Meeting Abstracts2012，120，21：	1
17	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，：	1
18	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia显示文摘	Grupp SA Kalos M Barrett D	2013	N Engl J Med2013，368，：	1
19	The angiogenesis inhibitor TNP 470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease显示文摘	Grupp SA Barr R	2001	Clin Cancer Res2001，7，4：	1
20	Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)显示文摘	Teachey DT Seif AE Grupp SA	2010	Br J Haematol2010，148，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示